Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as Adjuvant Therapy in Ulcerative Colitis
NCT04750135Phase 2Unknown
- Sponsor
- National Hepatology and Tropical Medicine Research Institute
- Start
- Feb 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in ulcerative colitis (UC), sponsored by National Hepatology and Tropical Medicine Research Institute. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04750135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04750135.